A review of drug patch testing and implications for HIV clinicians.
Shear
Neil H
NH
Dermatology and the Drug Safety Clinic, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Neil.Shear@sunnybrook.ca
Milpied
Brigitte
B
Bruynzeel
Derk P
DP
Phillips
Elizabeth J
EJ
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000633:toxicity*; D015224:Dideoxynucleosides / Q000633:toxicity; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019829:Nevirapine / Q000633:toxicity; D010328:Patch Tests / Q000379:methods*; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D019829:Nevirapine; D000099227:Abacavir